Navigation Links
Austen BioInnovation Institute and Lubrizol Announce New Strategic Innovation Partnership
Date:12/21/2011

AKRON, Ohio, Dec. 21, 2011 /PRNewswire-USNewswire/ -- The Austen BioInnovation Institute in Akron (ABIA) and The Lubrizol Corporation in Wickliffe jointly announce today a strategic partnership to share expertise while discovering, developing and commercializing novel and emerging technologies.

The partnership combines the polymer science and clinical orthopedic and wound care expertise of ABIA with Lubrizol, a key medical polymer innovator, globally recognized as a leader in the specialty chemical industry.  Participation in the ABIA program is meant to enhance the pace of innovation across a wide range of healthcare organizations, with the potential to increase research and development funding and employment in high-tech and high-growth sectors.

The partnership will provide Lubrizol opportunities for collaborative research and product development among industry, academia, clinical care and government; the ability to pursue 'big ideas' in pre-competitive research and development; and access to materials and biomaterials expertise and resources for future applications. In return, ABIA and those in its founding member institutions will have access to the expertise of an innovative and diverse corporation that has a global footprint and a history of chemistry, engineered polymers and consumer specialty products advancements in Europe, Asia and North America.

Deb Langer, Lubrizol general manager-lifescience polymers says, "Developing this relationship with ABIA will provide Lubrizol the opportunity to better understand a patient's needs in order to design and develop effective polymer solutions."

"Partnering with Lubrizol is strategically important for the Austen BioInnovation Institute and our region," says Dr. Frank L. Douglas, ABIA President and CEO. "It provides an opportunity to not only enhance new product development efforts in biomaterial applications in orthopedics and wound care, but also allows two Ohio-based entities to add to the regional and state economic capabilities and reach."

About the Austen BioInnovation Institute in Akron
The Austen BioInnovation Institute in Akron (ABIA) – an exceptional collaboration of Akron Children's Hospital, Akron General Health System, Northeast Ohio Medical University, Summa Health System, The University of Akron and the John S. and James L. Knight Foundation – is focused on patient-centered innovation and commercialization at the intersection of biomaterials and medicine. The strategic alignment of public and private support, accompanied with Akron's rich legacy in materials science, is working to pioneer the next generation of life-enhancing and life-saving innovation that will transform Akron into a model for biomedical discovery and enterprise and move the region toward a secure economic future by accelerating the creation of more than 2,000 jobs during the next decade. For more information about ABIA, please visit www.abiakron.org.

About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is an innovative specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, other transportation-related fluids and industrial lubricants, as well as fuel additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for personal care products and pharmaceuticals; specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives. Lubrizol's industry-leading technologies in additives, ingredients and compounds enhance the quality, performance and value of customers' products, while reducing their environmental impact.

With headquarters in Wickliffe, Ohio, The Lubrizol Corporation owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 7,000 employees worldwide. Revenues for 2010 were $5.4 billion. For more information, visit www.lubrizol.com.

Media Contacts
Lubrizol: Laura Hall, 216-447-6782, laura.hall@lubrizol.com
ABIA: Scott Rainone, 330-572-7581, srainone@abiakron.org 


'/>"/>
SOURCE Austen BioInnovation Institute in Akron
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices
2. Life Sciences Startup PhotOral Licenses Patented Oral Blue-Light Technology From Forsyth Institute
3. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
4. SRI International Awarded Contract Worth Up to $100M From National Institute of Allergy and Infectious Diseases
5. Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging
6. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
7. The Food and Drug Law Institute to Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf
8. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
9. Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
10. Russian Institute of Nutrition-Nutrilite Health Institute Collaboration Identifies Stress Markers Potentially Linked to Chronic Diseases in Overweight Russian Adults
11. Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of the ... based on extensive data analysis from GHI,s hospitals database ... database for the region. The GHI database covers 86% of ... more than 130 data points for each institution in key ...
(Date:5/9/2017)... -- Demonstrating its commitment to representing research- based biopharmaceutical ... Research and Manufacturers of America (PhRMA) today approved ... have to meet new research and development (R&D) ... PhRMA. "By putting in place new ... message that being a member of PhRMA means ...
(Date:5/6/2017)... May 5, 2017   Provista , a proven leader ... 200,000 customers, today announced Jim Cunniff as the ... executive and business experience to Provista, including most recently serving ... California . He assumed his new role ... a great fit for Provista," says Jody Hatcher , ...
Breaking Medicine Technology:
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head ... bold recipes for Memorial Day entertaining that are sure to satisfy your guests’ ... fresh sliced meats and cheeses featured in these refreshingly balanced recipes are packed ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... On May ... (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 ... expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using the ... can reconnect with America as it explores some of the best places to hike ... an inventive new place for a family vacation, and have discovered hiking. Many will ...
Breaking Medicine News(10 mins):